Sionna Therapeutics (SION) Non Operating Income (2024 - 2026)

Sionna Therapeutics has disclosed Non Operating Income across 3 years of filings, most recently posting $2.8 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $2.8 million, down 11.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.4 million (up 24.31% YoY), and the FY2025 annual result was $13.7 million, up 54.65% from the prior year.
• Non Operating Income came in at $2.8 million for Q1 2026 at Sionna Therapeutics, down from $3.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.8 million in Q2 2025 to a low of $1.3 million in Q1 2024.
• The 3-year median for Non Operating Income is $2.8 million (2026), against an average of $2.8 million.
• Across the five-year window, Non Operating Income soared 144.38% in 2025 and fell 11.24% in 2026, its largest moves.
• Sionna Therapeutics' Non Operating Income stood at $2.3 million in 2024, then soared by 38.82% to $3.2 million in 2025, then retreated by 11.1% to $2.8 million in 2026.
• The last three Non Operating Income figures came in at $2.8 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.